Key statistics
On Friday, Contineum Therapeutics Inc (CTNM:NSQ) closed at 14.44, -9.81% below its 52-week high of 16.01, set on Feb 11, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 15.15 |
|---|---|
| High | 15.39 |
| Low | 14.27 |
| Bid | 10.50 |
| Offer | 19.00 |
| Previous close | 14.88 |
| Average volume | 234.66k |
|---|---|
| Shares outstanding | 36.53m |
| Free float | 29.76m |
| P/E (TTM) | -- |
| Market cap | 527.49m USD |
| EPS (TTM) | -2.26 USD |
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
More ▼
- Contineum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Contineum Therapeutics Announces Pricing of Upsized $90.0 Million Public Offering
- Contineum Therapeutics Announces Proposed $75.0 Million Public Offering
- Contineum Therapeutics to Attend the 8th Annual Evercore Healthcare Conference
- Contineum Therapeutics Reports Topline Data From Its Phase 2 PIPE-307 VISTA Trial for the Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)
More ▼
